SCHEMBL9958894

SCHEMBL9958894

CCC(=O)Nc1cccc(C(=O)O)c1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
SMN1; SMN2 Q16637 5/20 0.60
SELP P16109 1/20 0.59
SELE P16581 1/20 0.59
NPC1 O15118 6/20 0.57
RAB9A P51151 6/20 0.57
KDM4E B2RXH2 5/20 0.57
CASP3 P42574 2/20 0.57
SENP8 Q96LD8 2/20 0.57
SENP7 Q9BQF6 2/20 0.57
SENP6 Q9GZR1 2/20 0.57
HSD17B10 Q99714 1/20 0.57
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
POLB P06746 1/20 0.51
SIRT5 Q9NXA8 1/20 0.51
CYP2C9 P11712 1/20 0.50
MITF O75030 1/20 0.50
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15329661 0.85 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2SELPSELENPC1
SCHEMBL29623849 0.85 BTK (0.57) ALDH1A1SMN1; SMN2SELPSELENPC1
SCHEMBL7235813 0.85 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2SELPSELENPC1
SCHEMBL4565885 0.84 SELP (0.61) ALDH1A1SMN1; SMN2SELPSELENPC1
SCHEMBL29543730 0.84 KMT2A (0.70) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL111479 0.84 KMT2A (0.70) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4294304 0.83 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2SELPSELENPC1
SCHEMBL10987960 0.82 SOAT1 (0.59) ALDH1A1SMN1; SMN2SELPSELENPC1
SCHEMBL10981533 0.82 SOAT1 (0.59) ALDH1A1SMN1; SMN2SELPSELENPC1
SCHEMBL10982243 0.82 SOAT1 (0.59) ALDH1A1SMN1; SMN2SELPSELENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655335-A1 NOVEL IMIDAZOLE-2-BENZAMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF OSTEOARTHRITIS Eli Lilly and Company (US) 2013-10-30 EP disclosed
WO-2012087771-A1 NOVEL IMIDAZOLE-2-BENZAMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF OSTEOARTHRITIS ELI LILLY AND COMPANY (US) 2012-06-28 WO disclosed